Denali Therapeutics
DNLI
#4389
Rank
โ‚ฌ1.56 B
Marketcap
10,75ย โ‚ฌ
Share price
-7.90%
Change (1 day)
-38.68%
Change (1 year)

Revenue for Denali Therapeutics (DNLI)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of โ‚ฌ0.29 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Denali Therapeutics from 2017 to 2024

Annual revenue

Year Revenue Change
2024 N/A-100%
2023 โ‚ฌ0.29 B195.7%
2022 โ‚ฌ0.10 B135.33%
2021 โ‚ฌ42.96 M-84.25%
2020 โ‚ฌ0.27 B1045.91%
2019 โ‚ฌ23.81 M-78.91%
2018 โ‚ฌ0.11 B
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.55 BN/A Jersey
โ‚ฌ0.62 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.11 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ19.92 MN/A๐Ÿ‡ฌ๐Ÿ‡ง UK